A Study to Assess the Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Osteoarthritis Patients
Phase of Trial: Phase I/II
Latest Information Update: 17 May 2017
Price : $35 *
At a glance
- Drugs Etoricoxib (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 10 Dec 2015 Treatment arms changed from 6 to 8 withaddition of Placebo deviation in part 1 study as reported by ClinicalTrials.gov.
- 16 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2014 Planned End Date changed from 1 Oct 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.